inositol 4,5-bisphosphate has been researched along with noladin ether in 1 studies
| Studies (inositol 4,5-bisphosphate) | Trials (inositol 4,5-bisphosphate) | Recent Studies (post-2010) (inositol 4,5-bisphosphate) | Studies (noladin ether) | Trials (noladin ether) | Recent Studies (post-2010) (noladin ether) |
|---|---|---|---|---|---|
| 29 | 0 | 10 | 40 | 0 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosino, P; Bíró, T; Calvigioni, D; Czifra, G; Di Marzo, V; Harkany, T; Iannotti, FA; Martella, A; Mazzarella, E; Petrosino, S; Piscitelli, F; Silvestri, C; Taglialatela, M | 1 |
1 other study(ies) available for inositol 4,5-bisphosphate and noladin ether
| Article | Year |
|---|---|
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels.
Topics: Animals; Arachidonic Acids; Cell Differentiation; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Endocannabinoids; Gene Silencing; Glycerides; Humans; Inositol Phosphates; KCNQ Potassium Channels; Mice; Muscle Development; Muscle Fibers, Skeletal; Muscle, Skeletal; Myoblasts, Skeletal; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Silicone Elastomers; Transfection | 2014 |